###begin article-title 0
VCAM-1 and VLA-4 Modulate Dendritic Cell IL-12p40 Production in Experimental Visceral Leishmaniasis
###end article-title 0
###begin p 1
Conceived and designed the experiments: ACS GRH PMK CRE. Performed the experiments: ACS JED SHR KPM YZ FR WAS AM CRE. Analyzed the data: ACS GRH PMK CRE. Wrote the paper: ACS CRE.
###end p 1
###begin p 2
###xml 323 342 323 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania donovani</italic>
###xml 525 526 525 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 701 712 701 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 775 776 775 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 323 342 <span type="species:ncbi:5661">Leishmania donovani</span>
###xml 701 712 <span type="species:ncbi:5661">L. donovani</span>
Vascular cell adhesion molecule-1 (VCAM-1) interacts with its major ligand very late antigen-4 (VLA-4) to mediate cell adhesion and transendothelial migration of leukocytes. We report an important role for VCAM-1/VLA-4 interactions in the generation of immune responses during experimental visceral leishmaniasis caused by Leishmania donovani. Our studies demonstrate that these molecules play no direct role in the recruitment of leukocytes to the infected liver, but instead contribute to IL-12p40-production by splenic CD8+ dendritic cells (DC). Blockade of VCAM-1/VLA-4 interactions using whole antibody or anti-VCAM-1 Fab' fragments reduced IL-12p40 mRNA accumulation by splenic DC 5 hours after L. donovani infection. This was associated with reduced anti-parasitic CD4+ T cell activation in the spleen and lowered hepatic IFNgamma, TNF and nitric oxide production by 14 days post infection. Importantly, these effects were associated with enhanced parasite growth in the liver in studies with either anti-VCAM-1 or anti-VLA-4 antibodies. These data indicate a role for VCAM-1 and VLA-4 in DC activation during infectious disease.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 230 249 230 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania donovani</italic>
###xml 453 464 453 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 771 782 771 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 230 249 <span type="species:ncbi:5661">Leishmania donovani</span>
###xml 453 464 <span type="species:ncbi:5661">L. donovani</span>
###xml 771 782 <span type="species:ncbi:5661">L. donovani</span>
VCAM-1 and its major ligand VLA-4 are adhesion molecules required for the recruitment and movement of leukocytes within tissue. In this study, we have investigated the role of these molecules during an experimental infection with Leishmania donovani, a protozoan parasite that causes a chronic disease called visceral leishmaniasis. Surprisingly, we showed that VCAM-1 and VLA-4 were not required for leukocyte migration into the liver, a site of acute L. donovani infection. Instead, there was a requirement for these molecules to initiate cell-mediated immune responses in the spleen within the first 5 hours of infection. When VCAM-1 was blocked during infection, early dendritic cell production of IL-12p40, a potent pro-inflammatory cytokine required for control of L. donovani, was suppressed, associated with a reduced parasite-specific T cell response in the spleen, and impaired immunity and parasite clearance in the liver. These results are important because they identify a novel role for VCAM-1 and VLA-4 in the regulation of dendritic cell activation during infectious disease.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 304 307 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Alon1">[1]</xref>
###xml 308 311 304 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Berlin1">[2]</xref>
###xml 426 429 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Lo1">[3]</xref>
###xml 498 501 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Levesque1">[4]</xref>
###xml 586 589 582 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Koopman1">[5]</xref>
###xml 691 694 687 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Carrasco1">[6]</xref>
###xml 703 706 699 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Mittelbrunn1">[7]</xref>
Very late antigen-4 (VLA-4; alpha4 integrin; CD49d) is expressed on most leukocytes and plays an important role in leukocyte trafficking by interacting with vascular cell adhesion molecule-1 (VCAM-1; CD106) on endothelial cells to mediate tethering, rolling, firm adhesion and transendothelial migration [1],[2]. This interaction has also been implicated in the compartmentalisation of B cells into peripheral lymphoid tissue [3], the association of neutrophils with bone marrow (BM) stromal cells [4], the promotion of interactions between follicular dendritic cells (FDC) and B cells [5], and more recently, in the formation of a docking structure that surrounds the B cell receptor (BCR) [6] and TCR [7] in the immunological synapse (IS) that forms between antigen presenting cells and antigen-specific B and T cells.
###end p 6
###begin p 7
###xml 38 57 38 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania donovani</italic>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda1">[8]</xref>
###xml 541 544 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray1">[9]</xref>
###xml 545 549 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray3">[11]</xref>
###xml 811 815 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda2">[12]</xref>
###xml 816 820 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato1">[13]</xref>
###xml 1077 1088 1073 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1101 1105 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray4">[14]</xref>
###xml 1106 1110 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda3">[16]</xref>
###xml 38 57 <span type="species:ncbi:5661">Leishmania donovani</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 1077 1088 <span type="species:ncbi:5661">L. donovani</span>
Visceral leishmaniasis (VL) caused by Leishmania donovani infection in genetically susceptible C57BL/6 or BALB/c mice results in parasite replication in the liver, spleen and BM [8]. The liver is the site of an acute, resolving infection, associated with leukocyte recruitment to infected resident Kupffer cells (KC) and the subsequent generation of a localised inflammatory response (granuloma formation), that includes the production of IFNgamma, TNF and reactive oxygen and nitrogen species, necessary for killing intracellular parasites [9]-[11]. In contrast, a chronic infection is established in the BM and spleen, associated with major changes to tissue architecture in the latter organ, including the loss of marginal zone (MZ) macrophages and stromal cells in the periarteriolar lymphoid sheath (PALS) [12],[13]. Interestingly, despite long-term parasite persistence in the spleen, this tissue is an important site for early dendritic cell (DC) IL-12p40 production that plays a key role in the generation of anti-parasitic immunity required for the control of hepatic L. donovani replication [14]-[16].
###end p 7
###begin p 8
###xml 73 84 73 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 446 450 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda4">[17]</xref>
###xml 533 544 525 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 977 978 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1026 1037 1014 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 73 84 <span type="species:ncbi:5661">L. donovani</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 533 544 <span type="species:ncbi:5661">L. donovani</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 1026 1037 <span type="species:ncbi:5661">L. donovani</span>
We recently showed that VCAM-1 was expressed on hepatic sinusoids during L. donovani infection in C57BL/6 mice. Furthermore, we demonstrated that VCAM-1 expression during infection required lymphotoxin alpha (LTalpha) and that in LTalpha-deficient C57BL/6 mice, the absence of VCAM-1 was associated with a failure of leukocytes to migrate from periportal areas to infected KC during granuloma formation, coincident with increased parasite growth [17]. In this study, we investigated whether the lack of VCAM-1 expression observed in L. donovani-infected mice deficient in LTalpha could explain their failure to recruit leukocytes into the liver and efficiently control parasite growth. Blockade of VCAM-1 or VLA-4 suppressed anti-parasitic immune responses and was associated with significantly higher hepatic parasite burdens. However, rather than directly mediating cellular recruitment to the liver during VL, our data indicate that VCAM-1 and VLA-4 play a role in rapid CD8+ DC IL-12p40 production in the spleen following L. donovani infection, an event critical for the generation of effective anti-parasitic immunity.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 72 83 72 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 72 83 <span type="species:ncbi:5661">L. donovani</span>
VCAM-1/VLA-4 interactions are critical for efficient control of hepatic L. donovani infection
###end title 10
###begin p 11
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 317 326 317 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g001">Figure 1A</xref>
###xml 417 428 417 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 428 431 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray1">[9]</xref>
###xml 608 617 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g001">Figure 1B</xref>
###xml 752 761 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g001">Figure 1C</xref>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 829 830 829 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1133 1144 1129 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1155 1158 1151 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray1">[9]</xref>
###xml 1159 1163 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray3">[11]</xref>
###xml 1164 1168 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda4">[17]</xref>
###xml 1295 1306 1291 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g001">Figure 1D&#8211;F</xref>
###xml 1519 1527 1515 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g002">Figure 2</xref>
###xml 1669 1680 1665 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 105 116 <span type="species:ncbi:5661">L. donovani</span>
###xml 276 279 <span type="species:ncbi:10116">rat</span>
###xml 417 428 <span type="species:ncbi:5661">L. donovani</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 1133 1144 <span type="species:ncbi:5661">L. donovani</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 1669 1680 <span type="species:ncbi:5661">L. donovani</span>
To investigate the role of VCAM-1 in VL, C57BL/6 mice were administered anti-VCAM-1 mAb 5 hours prior to L. donovani infection and then every third day thereafter until 14 days p.i. Hepatic parasite burdens were significantly increased (p<0.01) in these animals compared with rat IgG-treated controls at day 14 p.i. (Figure 1A). In addition, hepatic granuloma formation, an important process for efficient control of L. donovani[9], was significantly impaired in these mice with an increase in the frequency of infected KC and a decrease in the frequency of immature (IG) and mature granulomas (MG) (p<0.01; Figure 1B). As expected, this was associated with a dramatic decrease (p<0.01) in leukocyte recruitment to the liver following VCAM-1 blockade (Figure 1C), with the recruitment of all leukocytes studied (CD4+ T cells, CD8+ T cells, NKT cells, NK cells, B cells, macrophages/monocytes, neutrophils and DC) being significantly and similarly reduced (data not shown). IFNgamma, TNF and reactive nitrogen intermediates (RNI; measured using nitric oxide synthase (NOS-2) as a surrogate marker) are all critical for the control of L. donovani infection [9]-[11],[17], and mRNA encoding all of these molecules was significantly reduced (p<0.05) in the livers of mice receiving anti-VCAM-1 mAb (Figure 1D-F) at day 14 p.i. To confirm that VLA-4 was the main integrin interacting with VCAM-1 during VL, we also blocked this molecule using antibody over the first 14 days of infection, and obtained very similar results (Figure 2). Together these data indicate that VCAM-1/VLA-4 interactions play an important role in the generation of hepatic immune responses following L. donovani infection.
###end p 11
###begin title 12
###xml 44 55 44 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 44 55 <span type="species:ncbi:5661">L. donovani</span>
VCAM-1 is required for efficient control of L. donovani infection in the liver.
###end title 12
###begin p 13
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 122 133 122 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 475 486 473 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 79 82 <span type="species:ncbi:10116">rat</span>
###xml 151 155 <span type="species:ncbi:10090">Mice</span>
###xml 475 486 <span type="species:ncbi:5661">L. donovani</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
Female C57BL/6 mice were treated with anti-VCAM-1 mAb (closed bars) or control rat IgG (open bars) and infected with 2x107L. donovani amastigotes i.v. Mice were injected i.p. with 1 mg of antibody prior to infection and every 3 days thereafter. Parasite burdens were determined in the liver at day 14 p.i. (A) and data represent the mean+/-SEM in Leishman Donovan units. The number and maturity of hepatic granulomas were estimated on day 14 liver sections stained with anti-L. donovani sera (B). Data represent the frequency of infected Kupffer cells (KC), immature granulomas (IG) and mature granulomas (MG) per liver. Hepatic mononuclear cells were isolated from naive (hatched bars) and infected mice on day 14 p.i. and enumerated (C). mRNA was extracted from livers of naive or day 14 p.i. VCAM-1 blocked or control mice, and accumulation of IFNgamma (D), TNF (E) and NOS-2 (F) mRNA was detected by real-time RT-PCR and is expressed as mRNA molecule per 1000 HPRT molecules. One representative experiment of two performed with similar outcome is shown (n = 4 mice per treatment group in each experiment). Statistical differences of p</=0.05 (*) or p<0.01 (**) for control versus anti-VCAM-1 treatment are indicated.
###end p 13
###begin title 14
###xml 43 54 43 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 43 54 <span type="species:ncbi:5661">L. donovani</span>
VLA-4 is required for efficient control of L. donovani infection in the liver.
###end title 14
###begin p 15
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 121 132 121 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 473 484 471 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 78 81 <span type="species:ncbi:10116">rat</span>
###xml 150 154 <span type="species:ncbi:10090">Mice</span>
###xml 473 484 <span type="species:ncbi:5661">L. donovani</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
Female C57BL/6 mice were treated with anti-VLA-4 mAb (closed bars) or control rat IgG (open bars) and infected with 2x107L. donovani amastigotes i.v. Mice were injected i.p. with 1 mg of antibody prior to infection and every 3 days thereafter. Parasite burdens were determined in the liver at day 14 p.i. (A) and data represent the mean+/-SEM in Leishman Donovan units. The number and maturity of hepatic granulomas was estimated on day 14 liver sections stained with anti-L. donovani sera (B). Data represent the frequency of infected Kupffer cells (KC), immature granulomas (IG) and mature granulomas (MG) per liver. Hepatic mononuclear cells were isolated from naive (hatched bars) and infected mice on day 14 p.i. and enumerated (C). mRNA was extracted from livers of naive (hatched bars) or day 14 p.i. VLA-4 blocked (closed bars) or control mice (open bars), and accumulation of IFNgamma (D), TNF (E) and NOS-2 (F) mRNA was detected by real-time RT-PCR and is expressed as mRNA molecule per 1000 HPRT molecules. One representative experiment of two performed with similar outcome is shown (n = 4 mice per treatment group in each experiment). Statistical differences of p<0.05 (*) or p<0.01 (**) for control versus anti-VLA-4 treatment are indicated.
###end p 15
###begin title 16
###xml 100 111 100 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 100 111 <span type="species:ncbi:5661">L. donovani</span>
VCAM-1/VLA-4 interactions do not play a direct role in leukocyte recruitment to the liver following L. donovani infection
###end title 16
###begin p 17
###xml 113 124 113 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 351 352 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 367 368 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 378 379 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 569 578 565 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g003">Figure 3A</xref>
###xml 610 625 606 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g003">Figure 3B and C</xref>
###xml 674 683 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g003">Figure 3D</xref>
###xml 923 934 919 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 113 124 <span type="species:ncbi:5661">L. donovani</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 923 934 <span type="species:ncbi:5661">L. donovani</span>
To determine whether VCAM-1/VLA-4 interactions play a direct role in cellular recruitment to the liver following L. donovani infection, we delayed VCAM-1 or VLA-4 blockade until 3 days after infection. We chose this time point to begin blockade because no significant cellular recruitment to the liver had occurred before this time (3.85x106+/-4.48x105 versus 4.22x106+/-7.86x105 hepatic leukocytes in naive versus day 3 p.i. mice, respectively). In contrast to blockade commenced prior to infection, this delayed blockade failed to have any effect on parasite burden (Figure 3A), the formation of granulomas (Figure 3B and C), or numbers of hepatic mononuclear cells (MNC; Figure 3D), indicating that VCAM-1/VLA-4 interactions played no role in leukocyte recruitment to the liver. Therefore, the main role for VCAM-1/VLA-4 interactions in VL appeared to be in the generation of immune responses within the first 3 days of L. donovani infection.
###end p 17
###begin title 18
###xml 92 103 92 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 92 103 <span type="species:ncbi:5661">L. donovani</span>
VCAM-1/VLA-4 interactions are not required for leukocyte migration into the liver following L. donovani infection.
###end title 18
###begin p 19
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 174 185 174 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 604 615 602 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 131 134 <span type="species:ncbi:10116">rat</span>
###xml 203 207 <span type="species:ncbi:10090">Mice</span>
###xml 604 615 <span type="species:ncbi:5661">L. donovani</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 795 800 <span type="species:ncbi:10090">mouse</span>
###xml 867 871 <span type="species:ncbi:10090">mice</span>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
Female C57BL/6 mice were untreated (vertical hatched bar) or treated with anti-VCAM-1 mAb, anti-VLA-4 mAb (closed bars) or control rat IgG (open bars) and infected with 2x107L. donovani amastigotes i.v. Mice were injected i.p. with 1 mg of antibody prior to infection and every 3 days thereafter (black bars), or starting from day 3 and every 3 days thereafter (grey bars). Parasite burdens were determined in the liver at day 14 p.i. (A) and data represent the mean+/-SEM in Leishman Donovan units. The number and maturity of hepatic granulomas was estimated on day 14 liver sections labelled with anti-L. donovani sera from VLA-4 blocked mice (B) and VCAM-1 blocked mice (C). Data represent the frequency of infected Kupffer cells (KC), immature granulomas (IG) and mature granulomas (MG) per mouse. Hepatic MNC were isolated from naive (hatched bars) and infected mice on day 14 p.i. and enumerated (D). One representative experiment of two performed with similar outcome is shown (n = 4 mice per treatment group in each experiment). Statistical differences of p<0.01 (**) for control versus anti-VCAM-1 or anti-VLA-4 treatment are indicated.
###end p 19
###begin title 20
###xml 53 64 53 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 53 64 <span type="species:ncbi:5661">L. donovani</span>
Early DC IL-12p40 production in the spleen following L. donovani infection
###end title 20
###begin p 21
###xml 93 104 93 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda3">[16]</xref>
###xml 507 518 507 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g004">Figure 4A</xref>
###xml 834 838 834 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 1074 1085 1074 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1431 1432 1427 1428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1465 1474 1461 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g004">Figure 4B</xref>
###xml 1494 1505 1490 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1588 1589 1584 1585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1679 1680 1675 1676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1692 1701 1688 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g004">Figure 4B</xref>
###xml 1800 1801 1796 1797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1823 1834 1819 1830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 93 104 <span type="species:ncbi:5661">L. donovani</span>
###xml 507 518 <span type="species:ncbi:5661">L. donovani</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1074 1085 <span type="species:ncbi:5661">L. donovani</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
###xml 1494 1505 <span type="species:ncbi:5661">L. donovani</span>
###xml 1823 1834 <span type="species:ncbi:5661">L. donovani</span>
We have previously demonstrated that DC IL-12p40 production in the spleen within 24 hours of L. donovani infection is critical for the efficient generation of immunity in the liver [15],[16]. However, the kinetics of DC IL-12p40 production, the relevance of other infected tissue sites for the generation of this cytokine and the specific DC sub-population responsible for IL-12p40 production remain unknown. Therefore, we first measured IL-12p40 mRNA levels in the spleen, liver and BM, the main sites for L. donovani infection, over the first 7 days of infection. We found that IL-12p40 production occurred predominantly in the spleen and peaked at 5 hours p.i. (Figure 4A). This pattern of production was also confirmed by analysis of IL-12p40 protein expression in spleen tissue sections (data not shown), as previously described [15]. The IL-12p40-producing DC were located in the PALS, as well in close proximity to the MZ (data not shown), as previously reported [15],[18]. To determine the specific DC subset producing IL-12p40, MACS-enriched DC from naive mice and L. donovani-infected mice 5 hours p.i., were labelled for CD11c, CD4 and CD8alpha, and intracellular IL-12p40 protein levels were measured by FACS. No IL-12p40 protein was detected in CD11c-negative cells from either naive or infected animals (data not shown), thereby identifying DC as the main source of IL-12p40. Small numbers of IL-12p40-producing CD11c+ DC were observed in naive mice (Figure 4B). Five hours after L. donovani infection, there was a 2-3 fold increase in the number of IL-12p40-producing CD11c+ DC, and virtually all of the increased IL-12p40 production could be attributed to the CD8+ DC subset (Figure 4B). Together, these data demonstrate that parasite-induced IL-12p40 is produced in the spleen by CD8+ DC within 5 hours of L. donovani infection.
###end p 21
###begin title 22
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 80 91 80 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 80 91 <span type="species:ncbi:5661">L. donovani</span>
IL-12p40 is produced rapidly and transiently in the spleen by CD8+ DC following L. donovani infection.
###end title 22
###begin p 23
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 33 44 33 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 465 476 465 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 948 949 948 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">Mice</span>
###xml 1272 1276 <span type="species:ncbi:10090">mice</span>
(A) Mice were infected with 2x107L. donovani amastigotes i.v. and sacrificed at 2 hr, 5 hr, 12 hr, 24 hr, 72 hr, 5 days and 7 days p.i. mRNA was extracted from the spleen (squares), liver (inverted triangles) and bone marrow (triangles) at each time point and accumulation of IL-12p40 mRNA was detected by real-time RT-PCR and is expressed as mRNA molecule per 1000 HPRT molecules. Data are representative of 3 mice per time point. (B) Mice were infected with 1x108L. donovani amastigotes i.v. and spleens were removed at 5 hr p.i. MACS-enriched DC were enumerated by labelling with anti-CD11c mAb and examined for expression of isotype control mAb or IL-12p40 (1,000,000 events collected, 10,000 events shown). Cells were then electronically gated, based on expression of IL-12p40, as indicated, and then examined for expression of CD4 and CD8 (5000 events shown). Gates were determined from an isotype control for IL-12p40, in which 0.8% of CD11c+ cells were shown to be positive. Numbers below rectangular gates indicate the percentage of cells in that gate, while numbers in the upper right hand corners of FACS profiles indicate the percentage of cells in the indicated quadrants. One representative experiment of three performed with similar outcome is shown (n = 4 mice per treatment group in each experiment).
###end p 23
###begin title 24
VCAM-1 co-localises with sinusoidal endothelial cells and MZ macrophages in close proximity with DC in the MZ of the spleen
###end title 24
###begin p 25
###xml 150 161 150 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Lu1">[19]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Lu1">[19]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Mackay1">[20]</xref>
###xml 642 651 642 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5A</xref>
###xml 680 681 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 712 721 712 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5B</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Kraal1">[21]</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 1131 1132 1131 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1135 1144 1135 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5B</xref>
###xml 1239 1240 1239 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1247 1248 1247 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1251 1260 1251 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5C</xref>
###xml 1309 1310 1309 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1331 1340 1331 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5D</xref>
###xml 1354 1355 1354 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1455 1456 1455 1456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1459 1475 1459 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figures 5C and D</xref>
###xml 1540 1556 1540 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figures 5C and D</xref>
###xml 1729 1730 1729 1730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1913 1914 1913 1914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 150 161 <span type="species:ncbi:5661">L. donovani</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
We next investigated where VCAM-1 was expressed in the spleen to identify cell populations that might influence the generation of immune responses to L. donovani infection, and in particular CD8+ DC IL-12p40 production. Studies in the mouse spleen have reported VCAM-1 expression associated with individual cells in the red pulp [19], within a broad zone in the MZ [19] and within the B and T cell zones, including on follicular dendritic cells [20]. We confirmed that the majority of VCAM-1 expression was in the red pulp region, and demonstrated that expression could also be detected on discreet cell populations in the MZ and white pulp (Figure 5A). In the red pulp, all F4/80+ macrophages expressed VCAM-1 (Figure 5B). However, blood flowing into the spleen is released into the marginal sinus before flowing across the MZ into the red pulp and returning to the circulation via a venous route [21], and the site where DC are first likely to encounter parasites and/or parasite antigens is the MZ [15],[18]. In the MZ, there was little overlap observed between staining for VCAM-1 and marginal metallophilic macrophages (MOMA-1+) (Figure 5B). In contrast, there was clear co-localisation of VCAM-1 expression with MZ macrophages (ERTR9+/SIGNR1+) (Figure 5C), and with sinusoidal endothelial cells (Meca-32+) located in the MZ (Figure 5D). Both VCAM-1+ MZ macrophages and endothelial cells were located in close proximity to discrete areas of DC (CD11c+) (Figures 5C and D). However, no clear VCAM-1 expression was observed on these DC (Figures 5C and D), a finding also confirmed by FACS analysis of VCAM-1 expression by splenic DC (data not shown). There was some co-localisation of VCAM-1 with reticular fibroblasts (ER TR7+) throughout the spleen (data not shown). Isotype control mAbs matched in concentration to each mAb did not show any staining (not shown). These results indicate that the major VCAM-1+ cells found in the MZ where DC expressing VLA-4 are first likely to contact parasites and/or parasite antigens are the sinusoidal endothelial cells and MZ macrophages.
###end p 25
###begin title 26
###xml 50 54 <span type="species:ncbi:10090">mice</span>
VCAM-1 expression in the spleens of naive C57BL/6 mice.
###end title 26
###begin p 27
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 519 520 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
(A) VCAM-1 localisation (green) in a tissue section from a naive mouse. Marginal metallophilic macrophages were stained with MOMA-1 mAb (red) allowing visualisation of red pulp (RP), white pulp (WP) and marginal zone (MZ) regions of the spleen, as indicated (x100) The tissue section was mounted in media containing DAPI to stain cell nuclei (blue). (B-D) Staining for VCAM-1 expression, red pulp macrophages (F4/80+), MM macrophages (MOMA-1+), MZ macrophages (ERTR9/SIGNR1+), MZ sinus-lining endothelial cells (Meca-32+) and DC (CD11c+) (x630) is shown in colours indicated above panels. White arrows in (C) and (D) indicate areas where VCAM-1+ cells (yellow) are in close proximity to DC (blue).
###end p 27
###begin title 28
VCAM-1/VLA-4 interactions are not required for lymphocyte or DC migration into the spleen
###end title 28
###begin p 29
###xml 112 123 112 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Lo1">[3]</xref>
###xml 408 419 408 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 685 696 685 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 800 811 800 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g006">Figure 6A&#8211;C</xref>
###xml 112 123 <span type="species:ncbi:5661">L. donovani</span>
###xml 408 419 <span type="species:ncbi:5661">L. donovani</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 685 696 <span type="species:ncbi:5661">L. donovani</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
We next investigated whether VCAM-1 blockade modulated DC and/or lymphocyte trafficking in the spleen following L. donovani infection. Previous work showed that lymphocyte entry into the spleen was not prevented by integrin blocking antibodies [3], and we also confirmed this result by measuring migration of labelled lymphocytes into the PALS following VCAM-1 blockade in naive animals and after 5 hours of L. donovani infection (data not shown). However, the role of cell adhesion molecules in DC entry into the spleen has not been previously investigated. Therefore, we monitored migration of labelled DC into the spleen following VCAM-1 blockade in naive mice and after 5 hours of L. donovani infection, but found no role for VCAM-1 in this process, regardless whether mice were infected or not (Figure 6A-C). Therefore, VCAM-1 blockade did not affect lymphocyte or DC migration into the spleen, although our data do not exclude a role for VCAM-1 in cell movement between distinct regions within the spleen.
###end p 29
###begin title 30
VCAM-1/VLA-4 interactions are not critical for DC migration into the spleen.
###end title 30
###begin p 31
###xml 184 185 180 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 195 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 320 321 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 321 332 317 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 95 98 <span type="species:ncbi:10116">rat</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 714 719 <span type="species:ncbi:10090">mouse</span>
Naive C57BL/6 mice were injected with 100 microg FITC-dextran i.v. followed by 1 mg of control rat IgG (A) or anti-VCAM-1 mAb (B) i.p. 24 hr later. Hoechst 33342-labelled splenic CD11c+ DC (1x106) were administered i.v. 1 hr following mAb injection. The following day mice were either left as naive or infected with 2x107L. donovani amastigotes i.v. and spleens were removed 5 hr later (24 hr post-cell transfer). The distribution of Hoechst 33342-labelled cells was analysed in 20 microm sections and photographed under UV illumination (x100). Data are representative of one of two experiments performed (n = 3 mice per group). The number of Hoechst 33342-labelled cells was determined from 15 fields of view per mouse spleen (x25 magnification) (C).
###end p 31
###begin title 32
VCAM-1/VLA-4 interactions play a critical role in splenic DC IL-12p40 production
###end title 32
###begin p 33
###xml 225 234 225 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7A</xref>
###xml 319 330 319 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 319 330 <span type="species:ncbi:5661">L. donovani</span>
To test whether VCAM-1/VLA-4 interactions play a direct role in DC IL-12p40 production, we blocked these molecules 12 hours prior to infection and measured IL-12p40 mRNA levels in DC isolated from the spleen at 5 hours p.i. (Figure 7A). In control-treated mice, DC IL-12p40 mRNA levels increased 2-3 fold 5 hours after L. donovani infection. VCAM-1 blockade inhibited 50-100% of DC IL-12p40 mRNA accumulation, while VLA-4 blockade reduced DC IL-12p40 mRNA levels by 50-90% (n = 4 experiments).
###end p 33
###begin title 34
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
VCAM-1/VLA-4 interactions are required for parasite-induced IL-12p40 mRNA accumulation by CD8+ DC.
###end title 34
###begin p 35
###xml 203 204 203 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 204 215 204 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 758 759 758 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 805 816 805 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1145 1146 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1153 1154 1145 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1354 1355 1346 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1393 1404 1385 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1617 1628 1609 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 83 86 <span type="species:ncbi:10116">rat</span>
###xml 145 148 <span type="species:ncbi:10116">rat</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 805 816 <span type="species:ncbi:5661">L. donovani</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 872 875 <span type="species:ncbi:10116">rat</span>
###xml 1298 1302 <span type="species:ncbi:10090">mice</span>
###xml 1393 1404 <span type="species:ncbi:5661">L. donovani</span>
###xml 1422 1426 <span type="species:ncbi:10090">mice</span>
###xml 1516 1519 <span type="species:ncbi:10116">rat</span>
###xml 1617 1628 <span type="species:ncbi:5661">L. donovani</span>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
###xml 2022 2026 <span type="species:ncbi:10090">mice</span>
(A) C57BL/6 mice were treated with 1 mg anti-VCAM-1 mAb, anti-VLA-4 mAb or control rat IgG or (B) with 1 mg anti-VCAM-1 Fab fragments or control rat IgG Fab fragments the day prior to infection with 1x108L. donovani amastigotes. CD11c+ DC were enriched by positive selection by MACS from the spleens of naive mice (hatched bars), or antibody treated mice (closed bars) or control treated mice (open bars) at 5 hr p.i. mRNA was extracted from MACS-enriched DC, and accumulation of IL-12p40 mRNA was detected by real-time RT-PCR. One representative experiment of four performed with similar outcome is shown (n = 4 mice per treatment group in each experiment). All data is expressed as IL-12p40 mRNA molecules per 1000 HPRT molecules. (C-D) MACS-enriched CD11c+ DC from naive C57BL/6 mice (hatched bars) or L. donovani-infected mice at 5 hr p.i. treated with either control rat IgG (open bars) or anti-VCAM-1 (closed bars), were sorted based on CD11c and MHC-II expression, followed by separation into CD8alpha-positive and CD8alpha-negative populations. Percentages of each gated population are indicated. (D) mRNA was extracted from purified CD8+ or CD8- DC populations, as indicated, and accumulation of IL-12p40 mRNA was detected by real-time RT-PCR. Data represent groups of pooled cells from 4 mice, repeated 3 times. (E) Proliferation of splenic CD4+ T cells from naive (hatched bars) or L. donovani-infected C57BL/6 mice (day 14 p.i.) that had received anti-VCAM-1 mAb, anti-VLA-4 mAb (closed bars) or control rat IgG (open bars), as indicated, in the presence of naive irradiated splenic APC pulsed with fixed L. donovani amastigotes. One representative experiment of two performed with similar outcome is shown (n = 4 mice per treatment group in each experiment). Data is presented as a stimulation index (SI) calculated by dividing the proliferation of each sample in response to parasite antigen by proliferation in culture media alone. Statistical differences of p<0.01 (**) for antibody versus control treated mice are indicated.
###end p 35
###begin p 36
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 83 75 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5</xref>
###xml 259 263 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Anderson1">[22]</xref>
###xml 264 268 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Drechsler1">[23]</xref>
###xml 561 572 545 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 664 673 648 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7B</xref>
###xml 855 864 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7B</xref>
###xml 1161 1165 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Morris1">[24]</xref>
###xml 1166 1170 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Macfarlane1">[25]</xref>
###xml 1301 1312 1285 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 524 527 <span type="species:ncbi:10116">rat</span>
###xml 561 572 <span type="species:ncbi:5661">L. donovani</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
###xml 1301 1312 <span type="species:ncbi:5661">L. donovani</span>
However, given the co-localisation of DC with VCAM-1+ cells in the spleen (Figure 5), it is possible that the ligation of Fcgamma receptors (FcgammaR) on DC by anti-VCAM-1 mAbs could suppress IL-12p40 production, as previously reported for human and mouse DC [22],[23]. Therefore, we next generated anti-VCAM-1 Fab' fragments that comprised the antigen binding region of the mAb, but have all FcgammaR binding domains removed, and hence, are unable to signal via FcgammaR. Splenic DC isolated from mice treated with control rat IgG Fab' fragments 5 hours after L. donovani infection had a significant accumulation of IL-12p40 mRNA, relative to DC from naive mice (Figure 7B). Importantly, IL-12p40 accumulation in splenic DC from mice treated with anti-VCAM-1 Fab' fragments was significantly reduced (p<0.01), compared with DC from control-treated mice (Figure 7B). The reduction of IL-12p40 mRNA accumulation with anti-VCAM-1 Fab' fragments was not as effective as with anti-VCAM-1 mAb, and this most likely reflects the very short half-life of Fab' fragments in plasma (around 1 hour) compared with mAbs (hours-days), and their rapid excretion by the kidney [24],[25]. Nevertheless, these data support the conclusion that specific blockade of VCAM-1 reduces DC IL-12p40 mRNA accumulation following L. donovani infection, and that this effect of anti-VCAM-1 mAb treatment was not caused by FcgammaR ligation on DC.
###end p 36
###begin p 37
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 216 225 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7C</xref>
###xml 290 301 286 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 446 447 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 557 558 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 615 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7D</xref>
###xml 679 688 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7D</xref>
###xml 719 728 715 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g004">Figure 4B</xref>
###xml 825 826 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1055 1056 1051 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1079 1090 1075 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 290 301 <span type="species:ncbi:5661">L. donovani</span>
###xml 328 331 <span type="species:ncbi:10116">rat</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 1079 1090 <span type="species:ncbi:5661">L. donovani</span>
###xml 1227 1231 <span type="species:ncbi:10090">mice</span>
###xml 1242 1245 <span type="species:ncbi:10116">rat</span>
To confirm that parasite-induced IL-12p40 mRNA accumulation in CD8+ DC was the main target of VCAM-1 blockade, we next sorted these cells following MACS enrichment, based on expression of CD11c, MHC-II and CD8alpha (Figure 7C), from naive animals or at 5 hours p.i. from mice infected with L. donovani that had received control rat IgG or anti-VCAM-1 mAb prior to infection. As expected, the majority of IL-12p40 mRNA accumulation occurred in CD8+ DC, and levels increased approximately 2-fold at 5 hours p.i. Importantly, this increase did not occur in CD8+ DC from mice in which VCAM-1 had been blocked (Figure 7D). There was some disparity between IL-12p40 mRNA accumulation (Figure 7D) and IL-12p40 protein levels (Figure 4B) in different DC subsets from naive mice, whereby virtually all IL-12p40 mRNA accumulated in CD8+ DC, but IL-12p40 protein expression was similar between DC subsets. This may reflect different rates of IL-12p40 mRNA turnover or protein retention in different splenic DC subsets. We also observed that a small proportion of CD8+ DC were infected with L. donovani amastigotes at 5 hours p.i., and that infection of these cells was not reduced by anti-VCAM-1 mAb (0.50+/-0.10% versus 0.37+/-0.11% for mice receiving rat IgG or anti-VCAM-1 mAb, respectively, determined from cytospins).
###end p 37
###begin p 38
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 117 128 117 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 302 313 302 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 430 429 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 478 486 478 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 538 549 538 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 670 679 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7E</xref>
###xml 754 755 754 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 832 833 832 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 911 920 911 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7E</xref>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1120 1121 1120 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1169 1170 1169 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1295 1296 1295 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1342 1353 1342 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 117 128 <span type="species:ncbi:5661">L. donovani</span>
###xml 302 313 <span type="species:ncbi:5661">L. donovani</span>
###xml 538 549 <span type="species:ncbi:5661">L. donovani</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 1342 1353 <span type="species:ncbi:5661">L. donovani</span>
Our data indicate that VCAM-1/VLA-4 interactions are important for splenic CD8+ DC IL-12p40 production 5 hours after L. donovani infection, and that this is important for the efficient generation of anti-parasitic T cell responses required for control of hepatic infection. To directly examine whether L. donovani-specific CD4+ T cell activation was affected by blockade of VCAM-1/VLA-4 interactions, we next isolated splenic CD4+ T cells at day 14 p.i., and re-stimulated them in vitro in the presence of naive, irradiated APC and fixed L. donovani amastigotes. There was little proliferation of splenic CD4+ T cells from naive animals in response to parasite antigen (Figure 7E). However, significant parasite-specific proliferation was observed in CD4+ T cells from control-treated mice, but this was significantly reduced in CD4+ T cell from animals that had received either anti-VCAM-1 or anti-VLA-4 mAbs (Figure 7E). There was no difference in CD4+ T cell proliferation in response to concanavalin A in any of the groups tested, indicating that blockade of VCAM-1/VLA-4 did not generally suppress or inactivate CD4+ T cells. Together, these data indicate that CD8+ DC require VCAM-1/VLA-4 interactions for IL-12p40 production, associated with the generation of effective anti-parasitic CD4+ T cell responses required for the control of L. donovani growth in the liver.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 92 103 92 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 389 390 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 553 554 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 748 749 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 812 823 808 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 92 103 <span type="species:ncbi:5661">L. donovani</span>
###xml 812 823 <span type="species:ncbi:5661">L. donovani</span>
The interaction between VCAM-1 and VLA-4 appears to be important for the outcome of hepatic L. donovani infection. However, these molecules play no role in the recruitment of leukocytes to the infected liver during VL, and there appears to be no clear role for LTalpha-dependent VCAM-1 expression on hepatic sinusoids. Instead, VCAM-1/VLA-4 interactions modulate IL-12p40 production by CD8+ DC in the spleen within hours of parasite challenge. Blockade of VCAM-1, along with its physiological ligand VLA-4, resulted in reduced IL-12p40 production by CD8+ DC. Studies with anti-VCAM-1 Fab' fragments also indicate a role for VCAM-1/VLA-4 interactions in DC IL-12p40 production. Blockade of VCAM-1 with antibodies was also associated with reduced CD4+ T cell proliferation in the spleen and impaired resistance to L. donovani in the liver. The spleen harbours a relatively low parasite burden at the early time points assessed in this study, and this was not affected by VCAM-1 or VLA-4 blockade (data not shown).
###end p 40
###begin p 41
###xml 37 48 37 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray4">[14]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda3">[16]</xref>
###xml 330 341 330 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murray5">[26]</xref>
###xml 395 396 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 454 443 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 565 573 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g004">Figure 4</xref>
###xml 784 788 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda3">[16]</xref>
###xml 37 48 <span type="species:ncbi:5661">L. donovani</span>
###xml 330 341 <span type="species:ncbi:5661">L. donovani</span>
###xml 443 454 <span type="species:ncbi:5661">L. donovani</span>
DC IL-12p40 production shortly after L. donovani infection plays a key role in the generation of anti-parasitic immune mechanisms and is critical for the effective control of VL [14],[16]. Recently, both IL-12p70 and IL-23, each utilising the IL-12p40 subunit, were found to be functionally important cytokines for the control of L. donovani infection [26]. We have demonstrated that splenic CD8+ DC are the major source of IL-12p40 following L. donovani infection, and that parasite-induced IL-12p40 production occurs transiently, peaking 5 hours after infection (Figure 4). This early IL-12p40 production is physiologically important because when it is blocked during the first 24 hours of infection there is a failure to effectively control parasite growth in the liver and spleen [16].
###end p 41
###begin p 42
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 720 731 720 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1039 1040 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1072 1088 1072 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figures 5A and B</xref>
###xml 1332 1348 1332 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figures 5C and D</xref>
###xml 1430 1433 1430 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Alon1">[1]</xref>
###xml 1434 1437 1434 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Berlin1">[2]</xref>
###xml 1452 1463 1452 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1757 1760 1757 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Lo1">[3]</xref>
###xml 1945 1956 1945 1956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1968 1976 1968 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g006">Figure 6</xref>
###xml 720 731 <span type="species:ncbi:5661">L. donovani</span>
###xml 1452 1463 <span type="species:ncbi:5661">L. donovani</span>
###xml 1945 1956 <span type="species:ncbi:5661">L. donovani</span>
The location of DC in the spleen is important during this early phase of infection and DC are required to migrate from the MZ into the PALS within the first 5 hours of infection in order for efficient T cell priming and maximal IL-12p40 production to occur [18]. This pattern of cell movement supports a model whereby parasites are rapidly taken up by macrophages in the MZ [15],[18], parasite antigen is then either transferred from these cells to DC or the DC directly acquire antigen in the MZ, and subsequently migrate into the PALS for T cell activation. Our data suggest that VLA-4/VCAM-1 interactions play a role in these events. Blockade of VCAM-1 did not affect splenic parasite burden in the first 24 hours of L. donovani infection (data not shown), suggesting that VLA-4/VCAM-1 interactions play no role in parasite uptake by macrophages. In addition, the acquisition of parasites by CD8+ DC was not prevented by VCAM-1 blockade. Histological examination of spleen tissue indicated that red pulp macrophages were the main VCAM-1+ cell population in the spleen (Figures 5A and B). However, these cells are spatially segregated from the IL-12p40-producing DC found in the MZ and T cell zones. In the MZ, sinus lining endothelial cells and MZ macrophages express VCAM-1, and importantly, are found in close proximity to DC (Figures 5C and D). VCAM-1 on endothelium can mediate cell adhesion and transendothelial migration [1],[2], and early in L. donovani infection endothelial VCAM-1 may be involved in either the adhesion of DC in the MZ or the movement of these cells into the PALS after antigen acquisition. However, previous work has shown that lymphocyte entry into the spleen is not prevented by blocking any single integrin, including VLA-4 [3], and we also observed no effect of VCAM-1 blockade on lymphocyte trafficking (data not shown) or on the retention of labelled naive DC in the spleen in naive animals and 5 hours after L. donovani infection (Figure 6). Therefore, a role for VCAM-1-mediated naive DC retention in the MZ is unlikely.
###end p 42
###begin p 43
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 83 74 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g005">Figure 5C</xref>
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda2">[12]</xref>
###xml 652 653 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 687 698 687 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 140 151 <span type="species:ncbi:5661">L. donovani</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 687 698 <span type="species:ncbi:5661">L. donovani</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
The other main VCAM-1+ cell population in the MZ were the MZ macrophages (Figure 5C). These cells are highly phagocytic and rapidly take up L. donovani after infection [15],[18]. Furthermore, these cells are lost from the spleen after a chronic infection becomes established (day 21-28 p.i.) via a TNF-dependent mechanism, disrupting cellular movement in this organ [12]. Therefore, VCAM-1 on MZ macrophages could mediate DC movement from the MZ into the PALS. Alternatively, it could mediate interactions between DC and MZ macrophages, allowing uptake of parasite antigen by DC and/or activation of DC. Attempts to adoptively transfer splenic DC (5x106) isolated from mice 5 hours post-L. donovani infection (time of peak IL-12p40 production) to mice receiving VCAM-1 blockade, thereby bypassing these early cellular interactions, failed to improve control of parasite growth, relative to control animals (data not shown). Although this result suggests that later cellular interactions might be VCAM-1 dependent, only a small proportion of transferred DC (less than 10%) were found in the spleen 24 hours after transfer. Therefore, we cannot exclude the possibility that the failure to overcome VCAM-1 blockade resulted from altered DC trafficking caused by infection or the fact that DC from infected mice are unable to traffic effectively back to the T cell zones within the spleen.
###end p 43
###begin p 44
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Mittelbrunn1">[7]</xref>
###xml 433 444 433 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 785 786 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 804 815 804 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 926 927 922 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 936 940 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Maroof1">[27]</xref>
###xml 962 963 958 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 992 1003 988 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 1254 1255 1250 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 433 444 <span type="species:ncbi:5661">L. donovani</span>
###xml 804 815 <span type="species:ncbi:5661">L. donovani</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 992 1003 <span type="species:ncbi:5661">L. donovani</span>
VLA-4 has also been localised at the centre of the peripheral supramolecular activation complex (pSMAC) that surrounds the TCR-peptide-MHC complexes localised at the centre of the SMAC in the IS [7]. We failed to detect VCAM-1 expression by DC in the spleen either prior to or during infection, thus questioning the potential for VLA-4/VCAM-1 interactions in the SMAC of any IS that formed between DC presenting parasite antigen and L. donovani-specific T cells in the spleen after infection. However, we cannot rule out the possibility that physiologically relevant VCAM-1 expression on splenic DC is present, but beyond the detection limits of the histological and FACS methods we have employed. All conventional DC subsets in the spleen are capable of T cell activation, and the CD8+ DC isolated from L. donovani-infected mice 5 hours p.i. promote IL-12/23p40-dependent skewing towards IFNgamma production by responding CD4+ T cells [27]. In addition, the CD8+ DC are capable of acquiring L. donovani amastigotes independent of VCAM-1 early after infection, and these infected cells are able to produce IL-12p40 (Maroof, unpublished). Our data also indicate that VCAM-1/VLA-4 interactions play an important role in the priming of parasite-specific CD4+ T cells.
###end p 44
###begin p 45
###xml 401 405 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Morris1">[24]</xref>
###xml 406 410 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Macfarlane1">[25]</xref>
Short-term (5 hr) experiments with anti-VCAM-1 Fab' fragments suggested that FcgammaR ligation on DC was not responsible for the observed reduced DC IL-12p40 production. However, blockade of VCAM-1 and the reduction of DC IL-12p40 with Fab' fragments was not as effective as whole mAb, perhaps due to their extremely short half-life and rapid excretion by the kidney due to their low molecular weight [24],[25]. Ideally we would have liked to confirm our results at day 14 with Fab' fragments, as well as whole mAb. However, it would not be possible to interpret the results of such long-term experiments accurately due to the limitations discussed above.
###end p 45
###begin p 46
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In conclusion, we have shown that VCAM-1/VLA-4 interactions modulate CD8+ DC IL-12p40 production and may play a role in the activation of parasite-specific CD4+ T cells during disease. Furthermore, our data indicate that VCAM-1 and VLA-4 are not directly involved in cellular recruitment to the liver during VL. These findings advance our understanding of the induction of cell-mediated immune responses following pathogen challenge, and identify a potential target for modulation to either enhance or suppress inflammation during disease.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 48
###begin p 49
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Inbred female C57BL/6 and BALB/c mice were purchased from the Australian Resource Centre (Canning Vale, Western Australia), and maintained under conventional conditions. All mice used were age-matched (6 to 10 weeks), and were housed under specific-pathogen free conditions. All animal procedures were approved and monitored by the Queensland Institute of Medical Research Animal Ethics Committee.
###end p 49
###begin title 50
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Parasites and infection of mice
###end title 50
###begin p 51
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Gorak1">[15]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Ato2">[18]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Maroof1">[27]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Smelt1">[28]</xref>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">later</italic>
###xml 1020 1024 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda4">[17]</xref>
###xml 0 11 <span type="species:ncbi:5661">L. donovani</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">Mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
L. donovani (LV9) was maintained by passage in BALB/c or B6.RAG-1-/- mice, and amastigotes were isolated from the spleens of chronically infected mice. Mice were infected by injecting 2x107 amastigotes intravenously via the lateral tail vein, killed at the times indicated in the text by CO2 asphyxiation and bled via cardiac puncture. In experiments examining DC IL-12p40 protein production, mice were infected with 1x108 amastigotes intravenously, as previously reported [15],[18],[27]. Spleens and perfused livers were removed and parasite burdens were determined from Diff-Quick-stained impression smears (Lab Aids, Narrabeen, Australia), and expressed in Leishman-Donovan units (the number of amastigotes per host nuclei multiplied by the organ weight) [28]. Liver and spleen tissue were also preserved in either RNAlater (Sigma-Aldrich, Castle Hill, Australia) or Tissue-Tek O.C.T. Compound (Sakura, Torrance, USA). Hepatic mononuclear cells (MNC) were isolated immediately following death as previously described [17].
###end p 51
###begin title 52
VCAM-1 and VLA-4 blockade
###end title 52
###begin p 53
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Miyake1">[29]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Miyake2">[30]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Carter1">[31]</xref>
###xml 30 33 <span type="species:ncbi:10116">rat</span>
###xml 77 80 <span type="species:ncbi:10116">rat</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 480 483 <span type="species:ncbi:10116">rat</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
###xml 1141 1144 <span type="species:ncbi:10116">rat</span>
Anti-VCAM-1 (MK2/7; CRL-1909, rat IgG1) [29] and anti-VLA-4 (P/S2; CRL-1911, rat IgG2b) [30] hybridomas were purchased from the American Type Culture Collection (Manassas, VA). Purified antibody was prepared from culture supernatants by protein G column purification (Amersham, Uppsala, Sweden) followed by endotoxin removal (Mustang membranes, Pall, East Hills, NY). For VCAM-1 and VLA-4 blockade, C57BL/6 mice were injected i.p. with 1 mg of appropriate mAb or purified control rat IgG (Sigma-Aldrich) on the day of infection and every three days thereafter, or as detailed in the text. This dosing regime was based on one previously used in a collagen-induced arthritis model [31], except that 0.5 mg doses were used in this study. In our hands, 0.5 mg doses only achieved partial blockade of DC IL-12p40mRNA accumulation and hepatic anti-parasitic immunity, compared with 1 mg doses, hence our use of the increased amounts of mAb. We also found that the anti-VLA-4 mAb could be detected on the surface of splenic lymphocytes for at least 72 hours following injection of 1 mg into naive mice (data not shown). Anti-VCAM-1 mAb and control rat IgG Fab fragments were generated using a commercial kit according to the manufacturer's instructions (Thermo Scientific, Rockford, IL).
###end p 53
###begin title 54
Histological response to hepatic infection
###end title 54
###begin p 55
###xml 79 90 75 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 553 557 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Murphy1">[32]</xref>
###xml 79 90 <span type="species:ncbi:5661">L. donovani</span>
###xml 174 178 <span type="species:ncbi:9925">goat</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
Acetone-fixed liver sections (6 microm) were labelled with hamster antisera to L. donovani amastigotes at a dilution of 1 in 1000. Labelling was detected with a biotinylated goat anti-hamster antibody (Vector Laboratories, Burlingame, CA). Sections were developed with Vector-Elite ABC kit, followed by 3,3'-diaminobenzidine substrate kit (Vector Laboratories). Granuloma density was determined from 25 fields of view per mouse liver (x40 magnification), and the maturation of granulomas was scored around infected Kupffer cells, as described elsewhere [32].
###end p 55
###begin title 56
Isolation of DC
###end title 56
###begin p 57
###xml 312 313 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 858 866 842 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000158-g007">Figure 7</xref>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
Spleens were digested in collagenase type IV (1 mg/ml; Worthington, Lakewood, NJ) and deoxyribonuclease I (0.5 mg/ml; Worthington) at room temperature for 45 minutes. Splenocytes were isolated by passing digested spleens through a 100 microm cell strainer, followed by red blood cell lysis (Sigma-Aldrich). CD11c+ DC were positively selected from splenocyte preparations using magnetic-activated cell sorting (MACS) with metallo-conjugated anti-mouse CD11c antibodies (N418) and positive selection columns, according to the manufacturer's instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). In some experiments, following MACS enrichment, DC were sorted into CD8alpha-positive and CD8alpha-negative populations by labelling with antibodies to CD11c, MHC-II and CD8alpha, and sorting on a MoFlo Cell Sorter (Dako, Botany, NSW, Australia), as shown in Figure 7.
###end p 57
###begin title 58
Flow cytometry
###end title 58
###begin p 59
###xml 959 962 <span type="species:ncbi:10116">Rat</span>
###xml 968 973 <span type="species:ncbi:10090">mouse</span>
###xml 988 991 <span type="species:ncbi:10116">rat</span>
###xml 997 1002 <span type="species:ncbi:10090">mouse</span>
###xml 1505 1509 <span type="species:ncbi:9913">calf</span>
Liver MNC or splenocytes were harvested and pre-incubated with CD16/32 mAb (2.4G2; grown in-house) to avoid non-specific binding of antibodies to FcgammaR. For the staining of cell surface antigens, cells were incubated with fluorochrome-conjugated or biotinylated mAbs on ice for 30 minutes followed by streptavidin incubation for an additional 30 minutes when required. T cells, NKT cells and NK cells were enumerated with allophycocyanin (APC)-conjugated anti-TCRbeta chain (H57-597), fluorescein isothiocyanate (FITC)-conjugated anti-CD4 (GK1.5), phycoerythrin (PE)-conjugated anti-CD8alpha (H1.2F3), and biotinylated anti-NK1.1 (PK136). B cells were enumerated using FITC-conjugated anti-CD19 (6D5) and APC-conjugated anti-B220 (RA3-6B2). DC were enumerated with APC-conjugated anti-CD11c (N418) and FITC- or PE-conjugated anti-I-A/I-E (MHC-II; M5/114.15.2). All mAbs were purchased from Biolegend (San Diego, CA) or BD Biosciences (Franklin Lakes, NJ). Rat anti-mouse CR3 (5C6) and rat anti-mouse GR-1 (RB6 8C5) were grown and biotinylated in house, and used to enumerate monocytes and granulocytes, respectively. Biotinylated antibodies were detected using Alexa Fluor 488-conjugated streptavidin (Invitrogen Life Technologies, Mount Waverley, Australia). Flow cytometric analysis was performed on a FACScalibur flow cytometer and analysed using Cell Quest Pro Software (BD Biosciences). For intracellular IL-12p40 staining, splenocytes were incubated for 4 hours at 37degreesC in 10% (v/v) foetal calf serum, RPMI containing 10 microg/ml brefeldin A (Sigma-Aldrich) prior to cell surface labelling with antibodies to CD11c, CD8alpha and CD4 (all from BD Biosciences). Cells were then washed and fixed in 1% (w/v) paraformaldehyde, before being washed in FACS buffer containing 0.1% (w/v) saponin (BDH, Lutterworth, UK) and stained with PE-conjugated anti-IL-12p40 (C15.6) or an isotype control mAb (both from BD Biosciences).
###end p 59
###begin title 60
DC cytospins
###end title 60
###begin p 61
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Sorted CD8+ and CD8- DC (1x105) in 100 microl FACS buffer were collected onto a glass slide using a Cytospin 3 centrifuge, according to the manufacturer's instructions (Shandon Scientific Ltd, Cheshire, UK), prior to staining with Diff-Quick (Lab Aids) to visualise host cell and parasite nuclei microscopically.
###end p 61
###begin title 62
Real Time Reverse Transcriptase-Polymerase Chain Reaction
###end title 62
###begin p 63
###xml 677 703 673 699 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTTGCAGATGAAGCCTTTGAAGA</named-content>
###xml 718 743 714 739 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GGAACGCACCTTTCTGGTTACA</named-content>
###xml 766 794 762 790 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GTTGGATACAGGCCAGACTTTGTTG</named-content>
###xml 809 837 805 833 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GATTCAACCTTGCGCTCATCTTAGGC</named-content>
Total RNA was extracted from bone marrow, spleen or liver tissue using TRIzol reagent (Invitrogen Life Technologies), and an RNeasy Mini Kit with on-column DNase digestion (Qiagen, Valencia, CA). Total RNA was extracted from purified DC using an RNeasy Mini Kit with on-column DNase digestion (Qiagen), according to the manufacturer's instructions. RNA samples were reverse transcribed into cDNA using the cDNA Archive Kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. The number of IFNgamma, TNF and NOS-2 cDNA molecules in each sample were calculated using Taqman Gene Expression Assays (Applied Biosystems), and the number of IL-12p40 (5' CTTGCAGATGAAGCCTTTGAAGA (forward) and 5' GGAACGCACCTTTCTGGTTACA (reverse)), and HPRT (5' GTTGGATACAGGCCAGACTTTGTTG (forward) and 5'GATTCAACCTTGCGCTCATCTTAGGC (reverse)) (house-keeping gene) cDNA molecules in each sample were calculated by real-time reverse transcriptase-polymerase chain reaction (rtPCR) using Platinum Sybr Green Master Mix (Invitrogen Life Technologies). All real-time reverse transcriptase-polymerase chain reactions (rtPCR) were performed on a Corbett Research RG-3000 Rotor Gene (Corbett Life Sciences, Sydney, Australia). Standard curves were generated with known amounts of cDNA for each gene, and the number of cytokine molecules per 1000 HPRT molecules in each sample was calculated.
###end p 63
###begin title 64
Lymphocyte and DC trafficking experiments
###end title 64
###begin p 65
###xml 380 381 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 447 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000158-Engwerda2">[12]</xref>
###xml 481 482 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 525 526 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 180 183 <span type="species:ncbi:10116">rat</span>
###xml 449 453 <span type="species:ncbi:10090">Mice</span>
###xml 606 610 <span type="species:ncbi:10090">Mice</span>
Mice were pre-injected with 100 microg FITC-dextran i.v. (200,000 MW, anionic, Invitrogen Life Technologies) to label marginal zone macrophages, followed by 1 mg of anti-VCAM-1 or rat IgG control antibody i.p. 24 hours later. Lymphocytes were isolated from naive splenocytes using Histopaque 1083 (Sigma), according to the manufacturer's instructions. Splenic lymphocytes or CD11c+ DC were labelled with Hoechst 33342, as described previously [12]. Mice were administered with 1x107 Hoechst 33342-labelled lymphocytes or 1x106 Hoechst 33342-labelled DC via the lateral tail vein 1 hour post mAb injection. Mice were sacrificed 3 hours following lymphocyte transfer and 24 hr following DC transfer, and spleens were removed and embedded in Tissue-Tek O.C.T. compound (Sakura). The distribution of Hoechst 33342-labelled cells was analysed in 20 microm sections mounted in Pro-long Gold anti-fade (Invitrogen Life Technologies) using a Carl Zeiss inverted fluorescent microscope under UV illumination.
###end p 65
###begin title 66
Confocal microscopy
###end title 66
###begin p 67
###xml 280 284 <span type="species:ncbi:9925">goat</span>
###xml 290 293 <span type="species:ncbi:10116">rat</span>
###xml 437 440 <span type="species:ncbi:10116">rat</span>
###xml 455 461 <span type="species:ncbi:10090">murine</span>
###xml 896 900 <span type="species:ncbi:9925">goat</span>
###xml 906 909 <span type="species:ncbi:10116">rat</span>
Tissue-Tek O.C.T. compound-preserved sections (6 microm) of spleen tissue were acetone fixed and labelled with anti-VCAM-1 (429; MVCAM.A, BD Bioscience) detected by direct conjugation to Alexa Fluor 647 using a monoclonal antibody labelling kit, or with a fluorochrome conjugated goat anti-rat antibody (both from Invitrogen Life Technologies). To identify cell populations the sections were then labelled with different combinations of rat antibodies to murine metallophilic macrophages (MOMA-1, Acris Antibodies, Hiddenhausen, Germany), marginal zone (MZ) macrophages (ERTR9, specific ICAM-3-grabbing nonintegrin-related 1 (SIGNR1), Bachem Ltd. Merseyside, UK), reticular fibroblasts (ERTR7, BMA Biomedicals, Augst, Switzerland), endothelial cells (Meca-32, BD Biosciences), FITC -conjugated CD11c (BD Biosciences) and Alexa Fluor 647-conjugated F4/80 (BD Biosciences). Fluorochrome conjugated goat anti-rat antibodies were used for detection of purified antibodies. Sections were mounted in Pro-long Gold anti-fade (Invitrogen Life Technologies) and visualized using a Carl Zeiss inverted LSM META 510 confocal microscope.
###end p 67
###begin title 68
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Antigen re-stimulation of splenic CD4+ T cells
###end title 68
###begin p 69
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 298 309 298 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 398 399 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 462 463 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 298 309 <span type="species:ncbi:5661">L. donovani</span>
Splenic CD4+ T cells were positively selected by MACS from splenocytes using metallo-conjugated anti-CD4 antibodies and positive selection columns, according to the manufacturer's instructions (Miltenyi Biotec). CD4+ T cells (5x104 cells per well) were stimulated with 2x106 paraformaldehyde-fixed L. donovani amastigotes, and 1x106 irradiated, naive C57BL/6 spleen cells at 37degreesC, 5% (v/v) CO2. After 72 hours of culture, cells were pulsed with 1 microCi [3H] thymidine for 18 hours, prior to measuring thymidine incorporation using a Betaplate reader, (Wallac, Turku, Finland).
###end p 69
###begin title 70
Statistical analysis
###end title 70
###begin p 71
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The statistical significance of differences between groups was determined using a Mann Whitney test or an unpaired Student's t test using GraphPad Prism version 4.03 for Windows (GraphPad Software, San Diego, CA) and p<0.05 was considered statistically significant. The distribution of hepatic histological responses were compared using X2 analysis with Microsoft Excel software. All data are presented as the mean values+/-standard errors unless otherwise stated.
###end p 71
###begin p 72
We thank Grace Chojnowski and Paula Hall for expert assistance with flow cytometry, Kaye Wycherley from Walter and Eliza Hall Medical Research Institute for sub-cloning and selecting a high producing MK2/7 cell line, Jean-Pierre Levescue from the Mater Medical Research Institute for helpful discussion about VCAM-1 and VLA-4, and Andrew Boyd and Michael Gerometta from QIMR for helpful advice on the generation of Fab' fragments. We also thank Ashraful Haque for critical review of the manuscript.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.
###end article-title 74
###begin article-title 75
alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow.
###end article-title 75
###begin article-title 76
Integrin-dependence of lymphocyte entry into the splenic white pulp.
###end article-title 76
###begin article-title 77
Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor.
###end article-title 77
###begin article-title 78
###xml 12 17 <span type="species:ncbi:9606">human</span>
Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways.
###end article-title 78
###begin article-title 79
B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1.
###end article-title 79
###begin article-title 80
VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses.
###end article-title 80
###begin article-title 81
Organ-specific immune responses associated with infectious disease.
###end article-title 81
###begin article-title 82
Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
###end article-title 82
###begin article-title 83
###xml 131 150 <span type="species:ncbi:5661">Leishmania donovani</span>
Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.
###end article-title 83
###begin article-title 84
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.
###end article-title 84
###begin article-title 85
###xml 86 105 <span type="species:ncbi:5661">Leishmania donovani</span>
A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.
###end article-title 85
###begin article-title 86
Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis.
###end article-title 86
###begin article-title 87
Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis.
###end article-title 87
###begin article-title 88
###xml 74 93 <span type="species:ncbi:5661">Leishmania donovani</span>
Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
###end article-title 88
###begin article-title 89
###xml 103 122 <span type="species:ncbi:5661">Leishmania donovani</span>
Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
###end article-title 89
###begin article-title 90
###xml 81 100 <span type="species:ncbi:5661">Leishmania donovani</span>
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.
###end article-title 90
###begin article-title 91
###xml 60 79 <span type="species:ncbi:5661">Leishmania donovani</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21.
###end article-title 91
###begin article-title 92
Integrin-mediated long-term B cell retention in the splenic marginal zone.
###end article-title 92
###begin article-title 93
Turning off follicular dendritic cells.
###end article-title 93
###begin article-title 94
Cells in the marginal zone of the spleen.
###end article-title 94
###begin article-title 95
T cell biasing by activated dendritic cells.
###end article-title 95
###begin article-title 96
FcgammaR cross-linking mediates NF-kappaB activation, reduced antigen presentation capacity, and decreased IL-12 production in monocytes without modulation of myeloid dendritic cell development.
###end article-title 96
###begin article-title 97
Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer.
###end article-title 97
###begin article-title 98
Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab'.
###end article-title 98
###begin article-title 99
###xml 13 32 <span type="species:ncbi:5661">Leishmania donovani</span>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.
###end article-title 99
###begin article-title 100
###xml 89 108 <span type="species:ncbi:5661">Leishmania donovani</span>
Temporal regulation of IL-12p70 and IL-12-related cytokines in splenic DC subsets during Leishmania donovani infection.
###end article-title 100
###begin article-title 101
Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
###end article-title 101
###begin article-title 102
###xml 33 39 <span type="species:ncbi:10090">murine</span>
A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture.
###end article-title 102
###begin article-title 103
Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis.
###end article-title 103
###begin article-title 104
Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.
###end article-title 104
###begin article-title 105
###xml 75 94 <span type="species:ncbi:5661">Leishmania donovani</span>
Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani.
###end article-title 105
###begin p 106
The authors have declared that no competing interests exist.
###end p 106
###begin p 107
This work was supported by grants from the Australian NHMRC and the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). CRE is an Australian NHMRC Career Development Fellow and GRH is an Australian NHMRC Practitioner Fellow.
###end p 107

